| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |